Teleflex lands FDA win for Arrow UltraQuik needles

January 25, 2013 by MassDevice staff

Medical device company Teleflex touts 510(k) clearance for its Arrow UltraQuik peripheral nerve block needles.

Teleflex logo

Limerick, Pa.-based Teleflex (NYSE:TFX) won FDA clearance for the latest in its line of peripheral nerve block needles, the Arrow UltraQuik.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp